Vaccine Antigen - Vaccines

Relevant Publications

Explaining seasonality increases perceived effectiveness of influenza vaccination: An experimental study.

Issue Release: 2025

Generating MVA-Vector Vaccine Candidates and Testing Them in Animal Models.

Issue Release: 2025

Sustained release of inactivated H1N1 virus from degradable microparticles for extended vaccination.

Issue Release: 2024

Enhancing in situ cancer vaccines using delivery technologies.

Issue Release: 2024

Administration sequence- and formation-dependent vaccination using acid-degradable polymeric nanoparticles with high antigen encapsulation capability.

Issue Release: 2024

Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice.

Issue Release: 2024

MIL-53(Al)-oil/water emulsion composite as an adjuvant promotes immune responses to an inactivated pseudorabies virus vaccine in mice and pigs.

Issue Release: 2024

Mastoparan-7 adjuvanted COBRA H1 and H3 hemagglutinin influenza vaccines.

Issue Release: 2024

Selenium nanoparticles enhance mucosal immunity against Mycobacterium bovis infection.

Issue Release: 2024

Protective efficacy and immune responses of largemouth bass (Micropterus salmoides) immunized with an inactivated vaccine against the viral hemorrhagic septicemia virus genotype IVa.

Issue Release: 2024

Sparsely PEGylated poly(beta-amino ester) polyplexes enhance antigen specific T-cell response of a bivalent SARS-CoV-2 DNA vaccine.

Issue Release: 2024

In Situ Characterization of Human Follicular Helper CD4 T Cells.

Issue Release: 2024

Comprehensive characterization of bacterial glycoconjugate vaccines by liquid chromatography - mass spectrometry.

Issue Release: 2024

Induction of antigen-specific immunity by mesoporous silica nanoparticles incorporating antigen peptides.

Issue Release: 2024

A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection.

Issue Release: 2024

Stability and antigenicity of Chlamydia muridarum major outer membrane protein antigen at body temperature.

Issue Release: 2024

Comparative immunogenic and immunoprotective activities of PCV2d Cap and Rep antigens delivered by an efficient eukaryotic expression system engineered into a Salmonella vaccine vector.

Issue Release: 2024

Detection of IgG antibodies against the receptor binding domain of the spike protein and nucleocapsid of SARS-CoV-2 at university students from Southern Mexico: a cross-sectional study.

Issue Release: 2024

PIKfyve, expressed by CD11c-positive cells, controls tumor immunity.

Issue Release: 2024

Development of T cell antigen-based human coronavirus vaccines against nAb-escaping SARS-CoV-2 variants.

Issue Release: 2024

Are There Any Risks Associated with Vaccines for People with Heart Disease?

Which Vaccines Have Shown to Lower Hospitalization Rates?

What are Multi-Dose Vials?

What Should You Do Before Getting Vaccinated?

How is HBV DNA related to Hepatitis B Vaccination?

How Are Safety Signals Managed?

How Does the CDC Ensure Vaccine Safety?

Who should get the HPV Vaccine?

What is the Pneumococcal Vaccine?

How Do Genetically Engineered Vaccines Work?

Partnered Content Networks

Relevant Topics